Hutch News

Hutch News

Stories tagged 'Brenda M Sandmaier'

Three's a charm in a triple-drug combination for transplant patients

A drug with a storied past offers a new edge against an old foe

Dec. 4, 2016 | By Sabin Russell / Fred Hutch News Service

Discovered nearly 45 years ago in the volcanic soils of fabled Easter Island in the Pacific, a drug first thought of as an antifungal agent has found a new purpose by boosting the survival of leukemia patients after blood stem cell transplants. In a clinical trial conducted by Fred Hutchinson Cancer Research Center, the addition of a third drug, sirolimus, to a standard two-drug regimen effectively cut in half the incidence of acute graft-vs.-host disease, or GVHD, a common and dangerous complication of these lifesaving procedures.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Oct. 13, 2016

Dr. David Maloney named cellular immunotherapy medical director at Fred Hutch, SCCA; Dr. Jim Kublin gets grant to study how gut bugs alter HIV vaccine response.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

June 24, 2016

View story >


A life in tune

Erlinda Santos balances science and song after more than four decades at Fred Hutch

Jan. 6, 2016 | By Bill Briggs / Fred Hutch News Service

Erlinda Santos, a research tech supervisor, has logged more than 40 years hunting for cures at Fred Hutch. She may also be the only Filipino-born scientist in the nation whose research is partially rooted in American crooners. Perry Como. Pat Boone. Elvis. In her childhood home outside Manila, her father was an electronics technician who bought and placed jukeboxes in local restaurants, maintaining the machines and reaping the coins patrons plunked in to hear 1950s dinner tunes. "We were brought up from those jukeboxes," she said.

View story >


From building toys to developing cures

At 80, transplant scientist Dr. Rainer Storb can't stop tinkering with — and solving — medical puzzles

Dec. 21, 2015 | By Susan Keown / Fred Hutch News Service

Dr. Rainer Storb loves seeing and catching up with his former patients - men and women saved by his own research. He's 80 with big research goals still ahead.

View story >


Good News at Fred Hutch

Dr. Rainer Storb receives $12.9M to study blood stem-cell therapies for immune deficiencies; Dr. Julie Overbaugh studies HIV 'superinfection' to provide clues for better vaccine design

July 9, 2015 | By Fred Hutch staff

Dr. Rainier Storb receives $12.9M to study stem-cell therapies for immune deficiencies; Dr. Julie Overbaugh studies HIV 'superinfection' to provide clues for better vaccine design

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.